Skip to main content

Animations

MJFF Publications

5401 - 5410 of 9036 Results
Title
Year
  • Year
  • 2018
  • 2019
  • 2018
  • 2018
  • 2019
  • 2019
  • 2019
  • 2018
  • 2018
  • 2019
  • Summary Details
    OPEN
    Title: Calpain-mediated tau fragmentation is altered in Alzheimer’s disease progression
    Journal Name: Scientific Reports
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41598-018-35130-y
    Citation Count: 53
  • Summary Details
    OPEN
    Title: Defective homologous recombination DNA repair as therapeutic target in advanced chordoma
    Journal Name: Nature Communications
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41467-019-09633-9
    Citation Count: 101
  • Summary Details
    OPEN
    Title: Effects of Novel Calpain Inhibitors in Transgenic Animal Model of Parkinson’s disease/dementia with Lewy bodies
    Journal Name: Scientific Reports
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41598-018-35729-1
    Citation Count: 26
  • Summary Details
    OPEN
    Title: Characterizing patient compliance over six months in remote digital trials of Parkinson’s and Huntington disease
    Journal Name: BMC Medical Informatics and Decision Making
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1186/s12911-018-0714-7
    Citation Count: 45
  • Summary Details
    OPEN
    Title: Brain tyrosinase overexpression implicates age-dependent neuromelanin production in Parkinson’s disease pathogenesis
    Journal Name: Nature Communications
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41467-019-08858-y
    Citation Count: 339
  • Summary Details
    OPEN
    Title: Reduced habit-driven errors in Parkinson’s Disease
    Journal Name: Scientific Reports
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41598-019-39294-z
    Citation Count: 16
  • Summary Details
    OPEN
    Title: Alzheimer’s disease phospholipase C-gamma-2 (PLCG2) protective variant is a functional hypermorph
    Journal Name: Alzheimer's Research & Therapy
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1186/s13195-019-0469-0
    Citation Count: 149
  • Summary Details
    OPEN
    Title: Benefits of pallidal stimulation in dystonia are linked to cerebellar volume and cortical inhibition
    Journal Name: Scientific Reports
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41598-018-34880-z
    Citation Count: 16
  • Summary Details
    OPEN
    Title: Tau protein aggregation is associated with cellular senescence in the brain
    Journal Name: Aging Cell
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1111/acel.12840
    Citation Count: 590
  • Summary Details
    OPEN
    Title: The Combination of DAT-SPECT, Structural and Diffusion MRI Predicts Clinical Progression in Parkinson’s Disease
    Journal Name: Frontiers in Aging Neuroscience
    Publisher: Frontiers Media SA
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3389/fnagi.2019.00057
    Citation Count: 26
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.